913388-56-4 Usage
Molecular structure
1H-Indole-1-carboxylic acid, 2-borono-5-(1-piperidinylmethyl)-, 1-(1,1-dimethylethyl) ester is a chemical compound with a unique molecular structure that features an indole ring system and a boronic acid group.
Functional groups
The molecule contains several functional groups, including a carboxylic acid group, a boronic acid group, a piperidine group, and an ester group.
Reactivity
The boronic acid group in the molecule is known for its reactivity with various nucleophiles, making it a useful intermediate in the synthesis of other compounds.
Biological activity
The compound has potential therapeutic properties due to its ability to target specific enzymes and receptors in the body, making it a valuable tool in drug discovery and development.
Use in medicinal chemistry
1H-Indole-1-carboxylic acid, 2-borono-5-(1-piperidinylmethyl)-, 1-(1,1-dimethylethyl) ester is commonly used as a building block in the synthesis of various pharmaceutical drugs and biologically active molecules.
Production of diverse compounds
The unique chemical structure and reactivity of the compound make it an important intermediate in the production of diverse compounds, further highlighting its significance in the field of medicinal chemistry and pharmaceutical research.
Check Digit Verification of cas no
The CAS Registry Mumber 913388-56-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,3,3,8 and 8 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 913388-56:
(8*9)+(7*1)+(6*3)+(5*3)+(4*8)+(3*8)+(2*5)+(1*6)=184
184 % 10 = 4
So 913388-56-4 is a valid CAS Registry Number.
InChI:InChI=1/C19H27BN2O4/c1-19(2,3)26-18(23)22-16-8-7-14(13-21-9-5-4-6-10-21)11-15(16)12-17(22)20(24)25/h7-8,11-12,24-25H,4-6,9-10,13H2,1-3H3
913388-56-4Relevant articles and documents
JAK INHIBITOR
-
Page/Page column 76, (2009/10/21)
A JAK inhibitor comprising, as an active ingredient, a nitrogen-containing heterocyclic compound represented by formula (I) {wherein W represents a nitrogen atom or -CH-; X represents -C (=O) - or -CHR4- (wherein R4 represents a hydrogen atom, or the like); R1 represents the formula described below [wherein Q1 represents-CR8-(wherein R8 represents a hydrogen atom, substituted or unsubstituted lower alkyl, or the like); Q2 represents -NR15- (wherein R15 represents a hydrogen atom, substituted or unsubstituted lower alkyl, or the like); and R5 and R6 may be the same or different and each represents a hydrogen atom, halogen, carboxy, substituted or unsubstituted lower alkyl, or the like], or the like; and R2 and R3 may be the same or different and each represents a hydrogen atom, halogen, substituted or unsubstituted lower alkyl, or the like} or a pharmaceutically acceptable salt thereof.
